用于治疗卵巢癌的 PRAME 和 CTCFL 反应性 TCR
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
47.2分
★★★☆☆
站内排序·非疗效
ALL SOURCES
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
The Landscape of Adoptive Cellular Therapies in Ovarian Cancer.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。